Pharmaceuticals
10 AbbVie executives
These ten AbbVie executives include the company's chairman and CEO, its CFO, its chief operations officer and its general counsel, along with senior vice presidents who lead oncology, neuroscience, aesthetics, international and U.S. specialty businesses. Readers can learn how AbbVie's leadership team approaches finance, operations, legal matters, R&D and commercial strategy.
Professionals to explore
01—10Azita Saleki, Ph.D.
LinkedInExperience: Executive Vice President, Chief Operations Officer · AbbVie
Executive Vice President, Chief Operations Officer at AbbVie, a current role dated from 2012. She says she leads a global team of scientific, manufacturing, engineering, quality and supply chain professionals responsible for supply and distribution of all AbbVie products, as well as several enterprise services.
Jason Smith
LinkedInExperience: SVP, AbbVie, and President, Neuroscience · AbbVie
SVP, AbbVie, and President, Neuroscience since February 2026. At AbbVie he was also SVP and Head of Europe Commercial Operations, AbbVie (2024–2026) and SVP and President, Allergan Aesthetics International (2020–2024), and he was SVP and President, Asia Pacific, Middle East and Africa at Allergan (2017–2020).
Jerome Bouyer
LinkedInExperience: SVP AbbVie & President International · AbbVie
SVP AbbVie & President International since January 2026, based in Chicago. At AbbVie he was also SVP AbbVie & President Immunology (2024–2026), SVP AbbVie & President Europe (2022–2024), Area Vice President- EEMEA (2019–2022) and VP & General Manager United Kingdom (2017–2019).
Mitchell Brin
LinkedInExperience: Sr. VP R&D & Chief Scientific Officer, BOTOX & Neurotoxins · AbbVie
Sr. VP R&D & Chief Scientific Officer, BOTOX & Neurotoxins at AbbVie since May 2020. At Allergan he was Sr. VP Global Drug Development & Chief Scientific Officer, BOTOX & Neurotoxins (2018–2020), Sr. VP Development (2004–2007) and VP Development (2001–2004); his profile also lists Sr. VP Global Drug Development & Chief Scientific Officer, BOTOX at Allergan from 2007 with no end date.
Nicole Mowad-Nassar
LinkedInExperience: Senior Vice President, AbbVie and President, Global Allergan Aesthetics · Allergan Aesthetics, an AbbVie Company
Senior Vice President, AbbVie and President, Global Allergan Aesthetics since September 2025, a role in which she says she leads the global business that drives the advancement of aesthetic medicine. At AbbVie she was Senior Vice President, AbbVie and President, Specialty and U.S. Therapeutics Operations (2023–2025) and Vice President, Commercial Analytics & Operations and AbbVie Patient Services (2020–2023).
Nisha Patel Burns
LinkedInExperience: Senior Vice President, AbbVie and President, Specialty and U.S. Therapeutics Operations · AbbVie
Senior Vice President, AbbVie and President, Specialty and U.S. Therapeutics Operations since September 2025. Her other AbbVie roles include Vice President, International Marketing and Commercial Operations (2023–2025), Vice President, Global Marketing, Immunology (2021–2023) and Vice President, US Gastroenterology (2019–2021).
Perry Siatis
LinkedInExperience: Executive Vice President, General Counsel and Secretary · AbbVie
Executive Vice President, General Counsel and Secretary at AbbVie since October 2022, responsible for helping set the strategy of AbbVie's legal team. At AbbVie, Perry Siatis also held Senior Vice President, Deputy General Counsel (2021–2022), Senior Vice President, Legal, Chief Ethics and Compliance Officer (2019–2021) and Vice President, Biotherapeutics & Legal (2013–2019).
Rob Michael
LinkedInExperience: Chairman of the Board and Chief Executive Officer · AbbVie
Chairman of the Board and Chief Executive Officer of AbbVie since July 2025, after serving as Chief Executive Officer (2024–2025), President and Chief Operating Officer (2023–2024) and Vice Chairman and President (2022–2023). He was also Vice Chairman, Finance and Commercial Operations and Chief Financial Officer at AbbVie (2021–2022).
Scott Reents
LinkedInExperience: Executive Vice President, Chief Financial Officer · AbbVie
Executive Vice President, Chief Financial Officer at AbbVie since November 2022, a role in which he says he is responsible for AbbVie's global financial and business technology operations. At AbbVie he was also Senior Vice President, Chief Financial Officer (2022), Vice President, Tax and Treasury (2019–2022) and Vice President, Tax (2013–2019).
Wulff-Erik von Borcke
LinkedInExperience: Senior Vice President, AbbVie, and President, Oncology · AbbVie
Senior Vice President, AbbVie, and President, Oncology since July 2023, and President, US Oncology at AbbVie since 2020. His profile also lists President at Pharmacyclics, an AbbVie Company, from 2015 with no end date, and Vice President Global Marketing at AbbVie (2013–2015).
Choose the right perspective
Match the executive's function or business unit to your question, since corporate officers and the presidents of individual therapeutic or regional businesses see different parts of AbbVie's decisions. Check the dates of each person's current and past AbbVie roles to see which periods and portfolios their experience covers.
Questions to take into the conversation
- 01How does AbbVie decide which late-stage assets or biotech acquisitions to pursue?
- 02What does AbbVie's leadership weigh when planning a product launch across the U.S. and international markets?
- 03How does AbbVie's operations organization evaluate manufacturing and supply partners?
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot and may describe past or present roles. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.
Request a correction or removal